These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemia. Estey EH Leukemia; 2013 Sep; 27(9):1803-12. PubMed ID: 23757301 [TBL] [Abstract][Full Text] [Related]
24. [Research progress of epigenetic drug decitabine in AML]. Zhang R; Li HM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1467-71. PubMed ID: 25338609 [TBL] [Abstract][Full Text] [Related]
26. Outpatient management following intensive induction or salvage chemotherapy for acute myeloid leukemia. Walter RB; Taylor LR; Gardner KM; Dorcy KS; Vaughn JE; Estey EH Clin Adv Hematol Oncol; 2013; 11(9):571-7. PubMed ID: 24518520 [TBL] [Abstract][Full Text] [Related]
27. Decitabine as salvage therapy for primary induction failure of acute myeloid leukemia. Niscola P; Neri B; Catalano G; Morino L; Giovannini M; Scaramucci L; Fratoni S; Noguera NI; Cordone I; de Fabritiis P Acta Oncol; 2017 Aug; 56(8):1120-1121. PubMed ID: 28406054 [No Abstract] [Full Text] [Related]
28. Effect of Decitabine Combined with Unrelated Cord Blood Transplantation in an Adult Patient with -7/EVI1+ Acute Myeloid Leukemia: a Case Report and Literature Review. Jiang YZ; Su GP; Dai Y; He HS; Huang LQ; Sun ZM; Huang DP Ann Clin Lab Sci; 2015; 45(5):598-601. PubMed ID: 26586716 [TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of decitabine in treatment of elderly patients with acute myeloid leukemia: A systematic review and meta-analysis. He PF; Zhou JD; Yao DM; Ma JC; Wen XM; Zhang ZH; Lian XY; Xu ZJ; Qian J; Lin J Oncotarget; 2017 Jun; 8(25):41498-41507. PubMed ID: 28489568 [TBL] [Abstract][Full Text] [Related]
30. The euphoria of hypomethylating agents in MDS and AML: is it justified? Sekeres MA Best Pract Res Clin Haematol; 2013 Sep; 26(3):275-8. PubMed ID: 24309530 [TBL] [Abstract][Full Text] [Related]